T1	Participants 128 196	previously untreated patients with extensive small cell lung cancer.
T2	Participants 198 288	One hundred and eleven previously untreated patients with extensive small cell lung cancer
T3	Participants 518 624	Ninety-six patients were evaluable for response and toxicity and additional 12 patients for toxicity only.
